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transcatheter closure of atrial septal defectsRaghda Ghonimy Elsheikh a,⇑, Mohamed Hegab b, Andras Szatmari ca Tanta University Hospital, Tanta; b Mahalla Cardiac Center, El Mmahalla El Kobra; c Hungarian Institute of Cardiology, Budapest
a,bEgypt, cHungaryBackground: Atrial septal defects (ASD) account for 10% of all congenital heart lesions and represent the third most
congenital cardiac defect seen in adults.
Objectives: Using strain and strain rate imaging (SRI) to assess right ventricular (RV) function in patients with
ASD and correlate the results with the level of N-terminal pro-brain natriuretic peptide (NT-proBNP) before and
after transcatheter closure.
Methods: At the Hungarian Institute of Cardiology, 27 females and 18 males (mean age 21.53 years) were diag-
nosed with ASD and admitted for percutaneous closure. Echocardiography was done to assess theleft ventricular
(LV), RV and left atrial (LA) diameters. For assessment of systolic RV function, we measured Tricuspid annular
plane systolic excursion (TAPSE), strain, and SRI. Amplatzer ASD closure was done under general anesthesia.
NT-proBNP levels were measured before and three months after closure.
Results: ASD closure was achieved in all patients. The mean ASD diameter was 15.15 mm. The size of the occlu-
der ranged from 10 to 24 mm. The mean LA diameter in the pre-closure group was significantly higher than the con-
trol; mean left ventricular end diastolic diameter (LVEDD) showed a non-significant difference from either the
control group or the post-closure group, while the mean right ventricular end diastolic diameter (RVEDD) markedly
reduced post-closure, and it was significantly higher than the control group. Global RV strain and peak systolic
strain rate (PSSR) were significantly higher in ASD group than in the control. The NT-proBNP levels were found
to be correlated with pulmonary arterial pressure (PAP), TAPSE, global RV strain and PSSR.
Conclusion: Volume overload induced by ASD is associated with increased strain values, which return to normal
after closure. NT-proBNP is a parameter which correlates to RV pressure, PAP and the amount of shunt volume
caused by an ASD.
 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
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Atrial septal defect (ASD) is the third most com-mon congenital cardiac defect encountered in
adults [1]. It accounts for almost 10% of all congen-
ital heart lesions. The most common complications1016–7315  2012 King Saud University.
Production and hosting by Elsevier B.V. All rights reserved.
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URL: www.ksu.edu.sa
http://dx.doi.org/10.1016/j.jsha.2012.08.003recorded in association are right ventricular
volume overload, congestive heart failure, atrial
arrhythmias and latter, the development of
pulmonary arterial hypertension (PAH) [1].
Quantitative assessment of right ventricular
(RV) function is still challenging due to its complexProduction and hosting by Elsevier
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not incorporated into daily clinical practice. How-
ever, its assessment is becoming of increasing
interest in certain cardiac diseases that affect the
right ventricle (pulmonary hypertension, pulmon-
ary stenosis, atrial, or ventricular septal defects
[2]). There are several limitations in assessing RV
ejection fraction (EF) using conventional echocar-
diography methods. Tissue Doppler techniques
can allow the quantification of myocardial function
[3]. Myocardial strain is a dimensionless index of
tissue deformation expressed as a fraction or per
cent change. Myocardial lengthening gives a posi-
tive and myocardial shortening a negative strain
value. Strain rate (SR) measures the local rate of
deformation per time unit [4,5].
Two-dimensional (2D) strain and SR analyses
are novel Doppler-independent techniques to ob-
tain these measurements of myocardial movement
and deformation [6]. They have been frequently
used to assess left ventricular (LV) function, but
rarely been used to examine RV function [7].
In response to an increase in right atrial (RA)
pressure and/or volume, atrial natriuretic peptide
(ANP) level ‘‘a cardiac neurohormone’’ will in-
crease in RA [8,9]. It is an important regulator of
the volume homeostasis [10]. It may be elevated
in patients with congenital and acquired heart dis-
ease [11]. In left heart failure, high brain natri-
uretic peptide (BNP) levels are associated with
impaired exercise capacity and a poor prognosis
[12,13], but the data is limited In right heart failure
(there are no data relating serum BNP levels to the
severity of RV failure and pulmonary pressure in
patients with ASD [14,15]).
Objective of the present study was to use strain
and strain rate imaging to assess right ventricular
function in patients with right ventricular volume
overload due to atrial septal defect and correlate
the results with the level of N-terminal pro-brain
natriuretic peptide (NT-proBNP) before and after
transcatheter closure.Subjects & methods
At the Hungarian Institute of Cardiology Buda-
pest, Hungary, 45 patients (27 females and 18
males) with a mean age of 21.53 ± 18.09 years
(range 5–67 years) were diagnosed with ASD and
admitted to the centre for percutaneous closure
between April 2008 and March 2009 after giving
their informed consent. Decision for ASD closure
was based upon haemodynamically significant
left-to-right shunt (>40% of pulmonary blood
flow) or echocardiographic signs of right heartdilation or shunt related symptoms. None of them
had a previous stroke, coronary artery disease,
pulmonary disease or a significant valvular lesion
(more than mild). Patients with ASD who had
other forms of congenital heart disease and/or
life-threatening arrhythmias were excluded from
the study. Patients with large ASD > 3 cm were ex-
cluded and sent for surgical correction.
The control group consisted of 40 healthy sex
and age-matched volunteers after obtaining their
informed consent as well. Echocardiography was
performed on the day before and three months
after percutaneous closure of the ASD.
Echocardiographic examination
Echocardiographic examination was performed
with the patient in the supine position or in left
lateral semi-recumbence according to the ASE
guidelines [16] using an ultrasound system (SO-
NOS 5500, Hewlett-Packard Company and Philips
Invisor C) equipped. Standard echocardiography
included parasternal long, parasternal short, api-
cal four-chamber, apical three-chamber, and api-
cal two-chamber views. LV, RV and left atrial
(LA) diameters were registered by M-mode in
the parasternal long-axis view.
RV systolic function was measured using tricus-
pid annular plane systolic excursion (TAPSE) by
conventional M-mode, peak systolic strain and
strain rate.
SRI was acquired from the tissue velocity imag-
ing (TVI) mode, frame rates varied from 99 to 134
frames per second, with a mean value of 116.
Analysis was performed offline using the built-in
Q analysis software (echo pack) to measure peak
systolic strain rate (PSSR) as the maximal negative
strain rate within 350 ms after the QRS complex.
A region of interest (ROI) was placed in the basal
part of the selected segment halfway between the
endocardium and epicardium. Auto-correction of
ROI location during systolic contraction accounted
for the inward motion of the ventricular wall to
keep the ROI halfway between the endocardium
and epicardium. Three consecutive beats were
analyzed and the mean was calculated. The spec-
tral pulsed Doppler signal was adjusted to obtain
a Nyquist limit of 40 cm/s, with low-wall filter
settings and minimum optimal gain. No angle cor-
rection was made. Electrocardiograms were simul-
taneously recorded in all cases.
Trans-catheter closure of atrial septal defect
Transcatheter ASD closure was conducted un-
der general anesthesia, with fluoroscopic and
transesophageal echocardiographic guidance in
Table 1. The clinical characteristics and haemodynamic data of
patients with ASD.
Parameter Patient group
Sex (male/female) 18/27
Age (years) 21.53
Height (cm) 156.22
Weight (kg) 62.02
ASD diameter by TEE (mm) 15.15
ASD balloon sizing (mm) 18.72
Device size (mm) 17.35
Mean PAP (mmHg) 35.91
Mean RAP (mmHg) 10.13
Mean RVSP (mmHg) 33.31
Qp/Qs 2.25
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previously described techniques, including ASD
sizing with a compliant balloon (AGA Medical)
and closure with an Amplatzer Atrial Septal Oc-
cluder (AGA Medical Corp., USA) [17]. Procedural
success was defined as the successful deployment
of an atrial septal occluder at the end of the
procedure.
NT-pro BNP analysis
Blood samples were collected from the antecubi-
tal vein before and three months after trans-cath-
eter closure of ASD. Plasma levels of NT-proBNP
concentrations were measured on the Elecsys–
2010 system (Roche Diagnostics) [18]. This assay
is an electrochemiluminescent sandwich immuno-
assay using two polyclonal antibodies directed at
the NT-proBNP molecule.Statistics
Data are analyzed using Microsoft Excel sheets.
The data are expressed as mean ± standard devia-
tion (SD), variables in patient and control group
or in patient group pre and post ASD closure were
compared using Student t test and correlations be-
tween NT-proBNP, tissue Doppler variables or PAP
were obtained by using multiple regression analy-
sis. P < 0.05 is considered statistically significant.Results
Transcatheter closure of ASD was achieved in all
patients with an Amplatzer ASD occluder device,
and no residual shunt was noted in the entire
study group. No major complications occurred
after the procedure. All patients had a single
device implanted. The clinical characteristics andMean PAP 
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Mean RAP 
10.13333333
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Figure 1. The haemodynamic dhaemodynamic data of patients with ASD are
listed in Table 1 and Fig. 1. The mean ASD diame-
ter was 15.2 ± 3.16 mm and the stretched diameter
was 18.7 ± 3.39 mm. The sizes of occluder ranged
from 10 to 24 mm, mean 17.35 ± 3.29, using sizing
balloon 24 mm of AGA Medical Corp, USA, AEW
0.03500 and Amplatzer sheath 9–10 French.
The mean pulmonary artery pressure (PAP) was
35.9 ± 7.86 mmHg; mean right atrial pressure (RAP)
was; 10.1 ± 2.04 mmHg, while mean right ventricular
systolic pressure (RVSP) was; 33.3 ± 6.63 mmHg. The
mean shunt volume was; Qp/Qs 2.25 ± 0.4.
At three months follow up, complete occlusion
of the ASD was demonstrated by transesophageal
echo (TEE) in all patients, and no significant resid-
ual shunting through the device using color
Doppler flow.
The echocardiographic measurements of the pa-
tients and the controls are given in Table 2. The
mean left atrial (LA) diameter 39.7 ± 2.02 mm in
the pre-ASD closure group that was significantly
higher than the control, P < 0.05; with a non-signif-
icant difference after closure; mean left ventricular
end diastolic dimension (LVEDD) was 49.1 ±Mean RVSP 
33.31111111
Qp/Qs 
2.251111111
ta of ASD Group
ata of the patients group.
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Table 2. The echocardiography variables pre, post ASD closure & in controls.
Control group ASD P-value pre and post
Pre Post
LA (mm) 35.5 39.7 39.9 N.S.
LVEDD (mm) 53.2 49.1 50.7 N.S.
RVEDD (mm) 26.4 35.4 28.8 <0.05
TAPSE (mm) 17.3 22.6 19.2 <0.05
Global strain 24.1 ± 0.5 22.2 ± 0.7 23.9 ± 0.4 <0.05
PSSR 1.4 ± 0.2 1.2 ± 0.5 1.4 ± 0.6 <0.05
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from either control group or post ASD closure
group. While mean right ventricular end diastolic
dimension (RVEDD) 35.41 ± 2.04 mm, that mark-
edly reduced post ASD closure, and it was signifi-
cantly higher than control group, P < 0.05.
Global right ventricular strain and PSSR were sig-
nificantly lower in control group than ASD pre-clo-
sure group (24.1 ± 0.5 vs. 22.2 ± 0.7, P < 0.05 for
global strain; and 1.4 ± 0.2 vs. 1.2 ± 0.5, P < 0.05
for PSSR respectively). In the post-device closure
group, there was significant reduction of the global
RV strain and the PSSR to be 23.9 ± 0.4 and
1.4 ± 0.6 respectively; there was a non-significant
difference between this group and control one.
There was also a significant reduction of the TAPSE
that decreased from 22.6 ± 0.06 mm in pre-ASD clo-
sure group to 19.2 ± 3.4 mm in post-ASD closure
group, P < 0.05. There was a positive correlation be-
tween NT-pro BNP levels in patients with ASD and
PAP (r = 0.74, P < 0.05); RA pressure (r = 0.77,
P < 0.05); RVSP (r = 0.82, P < 0.01), Qp/Qs (r = 0.71,
P < 0.05). It also correlated with TAPSE (r = 0.80,
P < 0.01), global RV strain (r = 0.72, P < 0.05) and
PSSR (r = 0.79, P < 0.05).Figure 2. Showed a significant reduction of mean peptide lAt three months after closure, there was a signif-
icant reduction of mean peptide level (Fig. 2) from
194 ± 87 pg/ml to 133 ± 35 pg/ml (P < 0.01).Discussion
In this study transcatheter closure of ASD was
achieved in 45 patients using an Amplatzer device
with no residual shunt in the entire patient group.
The mean ASD diameter was 15.2 ± 3.16 mm and
the stretched diameter was 18.72 ± 3.39 mm. The
size of the occluder ranged from 10 to 24 mm,
mean 17.35 ± 3.29. A sizing balloon of 24 mm of
AGA, AEW 0.03500 and an Amplatzer sheath 9–10
French was used. Our study group had average
or mild increased pulmonary artery pressure and
mean shunt volume was 2.25 ± 0.4. The mean left
atrial diameter in pre-ASD closure group was sig-
nificantly higher than the control (P < 0.05), with a
non-significant difference after closure; mean left
ventricular end diastolic dimension showed a
non-significant difference from either the control
group or post-ASD closure group. While the right
ventricular diameter decreased significantly afterevel (BNP) after atrial septal defect closure (P < 0.01).
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trol group (P < 0.05).
Few studies used 2D strain and SR analysis for
the assessment of the systolic RV function in pa-
tients with RV volume overload secondary to
ASD as Smita et al. [19], who concluded that
two-dimensional strain appears to be helpful for
the assessment of RV function and its response
to correction of volume overload. Our study dem-
onstrates that patients with RV volume overload
due to an ASD had increased strain values when
compared with age-matched healthy adults
(P < 0.05). The increased myocardial strain values
return to normal three months after trans-catheter
closure. Accordingly, we observed a significant
reduction of the TAPSE as well (P < 0.05). These
results correlated with that of Smita et al. [19].
We discovered that the Plasma NT-pro BNP
concentration correlated well with TAPSE, strain
and PSSR as well as pulmonary artery pressure,
right atrial pressure and right ventricular pres-
sure. Moreover, NT-pro BNP concentration before
closure of the defect showed good correlation with
the amount of inter-atrial left-to-right shunt. The
majority of data from previous studies showed
that plasma BNP levels and its co-released pep-
tide NT-pro BNP are linked to haemodynamic
indices of left ventricular function [20,21]. Only a
few reports deal with BNP levels in the context
of RV dysfunction [22]. The findings of the present
study are in agreement with the data of Schoen et
al. [23] who reported that Plasma NT-pro BNP
concentration measured in parallel to MRI scans
decreased with good correlation to the restitution
of RV dilatation. Muta et al. [24] who described
elevated BNP levels in pediatric patients with
ASD came with results similar to ours. Addition-
ally, Trojnarska et al. [25] reported on increased
BNP concentrations in adult patients with ASD.
Recently Weber et al. [26] postulated that NT-
pro BNP is not increased in patients with ASD.Conclusion
Transcatheter ASD closure techniques have be-
come an alternative to surgical procedure using
cardiopulmonary bypass. Two-dimensional strain
and SR measurements are a novel approach used
in assessment of global and regional myocardial
function. Right ventricular volume overload is
associated with increased strain values, which re-
turn to normal after abolishment of the volume
overload. SR seems to be less dependent on load
of the right ventricle. NT-pro BNP correlates to
right ventricular strain, pulmonary pressure andleft-to-right shunt in volume load of the right
heart caused by an underlying ASD.References
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